Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
IJU Case Rep ; 5(1): 53-56, 2022 Jan.
Article in English | MEDLINE | ID: mdl-35005474

ABSTRACT

INTRODUCTION: In Western countries, the risk of a testicular germ cell tumor in men with male factor infertility is greater than in the general population. However, Japanese data on this risk are lacking. Additionally, the clinical course for the pathogenesis involved has not been clearly characterized. CASE PRESENTATION: A 35-year-old Japanese male underwent a right orchiectomy because of a mass in his right scrotum. He had a previous history of microdissection testicular sperm extraction undertaken 6 years ago. The final diagnosis of the right scrotal mass was a stage I seminoma. However, a relapse occurred in the left inguinal lymph node 2 years after surgery and the patient was consequently treated with systemic chemotherapy. Pathological analysis of a microdissection testicular sperm extraction sample yielded a germ cell neoplasia in situ in the right testis. CONCLUSION: In Japan, men who seek an evaluation for infertility might be more likely to develop testicular germ cell tumor.

2.
Nutrients ; 14(1)2021 Dec 23.
Article in English | MEDLINE | ID: mdl-35010924

ABSTRACT

Non-alcoholic steatohepatitis (NASH) can cause liver cirrhosis and hepatocellular carcinoma (HCC), with cases increasing worldwide. To reduce the incidence of liver cirrhosis and HCC, NASH is targeted for the development of treatments, along with viral hepatitis and alcoholic hepatitis. Lactoferrin (LF) has antioxidant, anti-cancer, and anti-inflammatory activities. However, whether LF affects NASH and fibrosis remains unelucidated. We aimed to clarify the chemopreventive effect of LF on NASH progression. We used a NASH model with metabolic syndrome established using connexin 32 (Cx32) dominant negative transgenic (Cx32ΔTg) rats. Cx32ΔTg rats (7 weeks old) were fed a high-fat diet and intraperitoneally injected with dimethylnitrosamine (DMN). Rats were divided into three groups for LF treatment at 0, 100, or 500 mg/kg/day for 17 weeks. Lactoferrin significantly protected steatosis and lobular inflammation in Cx32ΔTg rat livers and attenuated bridging fibrosis or liver cirrhosis induced by DMN. By quantitative RT-PCR, LF significantly down-regulated inflammatory (Tnf-α, Il-6, Il-18, and Il-1ß) and fibrosis-related (Tgf-ß1, Timp2, and Col1a1) cytokine mRNAs. Phosphorylated nuclear factor (NF)-κB protein decreased in response to LF, while phosphorylated JNK protein was unaffected. These results indicate that LF might act as a chemopreventive agent to prevent hepatic injury, inflammation, and fibrosis in NASH via NF-κB inactivation.


Subject(s)
Lactoferrin/pharmacology , Liver Cirrhosis/prevention & control , NF-kappa B/metabolism , Non-alcoholic Fatty Liver Disease/drug therapy , Animals , Anticarcinogenic Agents/pharmacology , Carcinogenesis/drug effects , Carcinoma, Hepatocellular/drug therapy , Connexins/metabolism , Cytokines/metabolism , Dimethylnitrosamine/adverse effects , Fibrosis/prevention & control , Lactoferrin/administration & dosage , Liver/injuries , Liver Neoplasms/drug therapy , Male , Non-alcoholic Fatty Liver Disease/metabolism , Rats , Transforming Growth Factor beta1/metabolism , Tumor Necrosis Factor-alpha/metabolism , Gap Junction beta-1 Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...